These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 37990681

  • 1. Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review.
    Bays HE.
    Obes Pillars; 2023 Sep; 7():100076. PubMed ID: 37990681
    [Abstract] [Full Text] [Related]

  • 2. Hyperglycemia and antipsychotic medications.
    Haupt DW, Newcomer JW.
    J Clin Psychiatry; 2001 Sep; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [Abstract] [Full Text] [Related]

  • 3. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
    Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.
    Encephale; 2005 Sep; 31(4 Pt 1):507-16. PubMed ID: 16389718
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 5. Adiposopathy and epigenetics: an introduction to obesity as a transgenerational disease.
    Bays H, Scinta W.
    Curr Med Res Opin; 2015 Nov; 31(11):2059-69. PubMed ID: 26331354
    [Abstract] [Full Text] [Related]

  • 6. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
    Brown A, Guess N, Dornhorst A, Taheri S, Frost G.
    Diabetes Obes Metab; 2017 Dec; 19(12):1655-1668. PubMed ID: 28509408
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance and hyperinsulinemia in hypertension.
    Weidmann P, Böhlen L, de Courten M.
    J Hypertens Suppl; 1995 Aug; 13(2):S65-72. PubMed ID: 8576790
    [Abstract] [Full Text] [Related]

  • 8. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z.
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [Abstract] [Full Text] [Related]

  • 9. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C, Tsuchiya K, Shiba K, Miyachi Y, Furuke S, Shimazu N, Yamaguchi S, Kanno K, Ogawa Y.
    PLoS One; 2016 May; 11(3):e0151511. PubMed ID: 26977813
    [Abstract] [Full Text] [Related]

  • 10. Restoration of metabolic health by decreased consumption of branched-chain amino acids.
    Cummings NE, Williams EM, Kasza I, Konon EN, Schaid MD, Schmidt BA, Poudel C, Sherman DS, Yu D, Arriola Apelo SI, Cottrell SE, Geiger G, Barnes ME, Wisinski JA, Fenske RJ, Matkowskyj KA, Kimple ME, Alexander CM, Merrins MJ, Lamming DW.
    J Physiol; 2018 Feb 15; 596(4):623-645. PubMed ID: 29266268
    [Abstract] [Full Text] [Related]

  • 11. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J, Garvey WT.
    Curr Obes Rep; 2015 Jun 15; 4(2):287-302. PubMed ID: 26627223
    [Abstract] [Full Text] [Related]

  • 12. Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes.
    Gorgojo Martínez JJ.
    Med Clin (Barc); 2016 Nov 15; 147 Suppl 1():8-16. PubMed ID: 28760227
    [Abstract] [Full Text] [Related]

  • 13. TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Zhen Q, Yao N, Chen X, Zhang X, Wang Z, Ge Q.
    Endocr Pract; 2019 Mar 15; 25(3):270-278. PubMed ID: 30913011
    [Abstract] [Full Text] [Related]

  • 14. Atypical antipsychotics and glucose homeostasis.
    Bergman RN, Ader M.
    J Clin Psychiatry; 2005 Apr 15; 66(4):504-14. PubMed ID: 15816794
    [Abstract] [Full Text] [Related]

  • 15. Suppressing hyperinsulinemia prevents obesity but causes rapid onset of diabetes in leptin-deficient Lepob/ob mice.
    D'souza AM, Johnson JD, Clee SM, Kieffer TJ.
    Mol Metab; 2016 Nov 15; 5(11):1103-1112. PubMed ID: 27818936
    [Abstract] [Full Text] [Related]

  • 16. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW.
    CNS Drugs; 2005 Nov 15; 19 Suppl 1():1-93. PubMed ID: 15998156
    [Abstract] [Full Text] [Related]

  • 17. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.
    Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-Campoy JM, Jones SR, Kumar R, La Forge R, Samuel VT.
    J Clin Lipidol; 2013 Nov 15; 7(4):304-83. PubMed ID: 23890517
    [Abstract] [Full Text] [Related]

  • 18. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat.
    den Hartigh LJ, Goodspeed L, Wang SA, Kenerson HL, Omer M, O'Brien KD, Ladiges W, Yeung R, Subramanian S.
    Exp Physiol; 2018 Nov 15; 103(11):1469-1480. PubMed ID: 30117227
    [Abstract] [Full Text] [Related]

  • 19. Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
    Purnell JQ, Weyer C.
    Treat Endocrinol; 2003 Nov 15; 2(1):33-47. PubMed ID: 15871553
    [Abstract] [Full Text] [Related]

  • 20. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M, Bursey D.
    Pediatrics; 2001 Apr 15; 107(4):E55. PubMed ID: 11335776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.